AXA (OTCMKTS:AXAHY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday.

According to Zacks, “The AXA Group is an international group of insurance and related financial services companies. AXA’s insurance operations are diverse geographically, with activities in 50 countries, principally Western Europe, North America and the Asia/Pacific area. In the United States, AXA is represented through its 60% holding in The Equitable companies and its subsidiaries, Equitable Life, Alliance Capital management and Donaldson, Lufkin & Jenrette. “

Several other research firms also recently commented on AXAHY. Barclays reissued an “equal weight” rating on shares of AXA in a research note on Monday, November 26th. Citigroup raised shares of AXA from a “neutral” rating to a “buy” rating in a research note on Thursday, January 17th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. AXA currently has an average rating of “Buy” and a consensus price target of $29.00.

AXAHY stock opened at $23.08 on Tuesday. The company has a market cap of $56.71 billion, a price-to-earnings ratio of 7.90, a price-to-earnings-growth ratio of 1.65 and a beta of 1.03. AXA has a one year low of $20.84 and a one year high of $31.95.

About AXA

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates through six segments: France, Europe, Asia, the United States, International, and Transversal and Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Further Reading: How Do Investors Open a Backdoor Roth IRA?

Get a free copy of the Zacks research report on AXA (AXAHY)

For more information about research offerings from Zacks Investment Research, visit

Analyst Recommendations for AXA (OTCMKTS:AXAHY)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with's FREE daily email newsletter.